Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: LJM who wrote (2714)	1/25/2011 12:20:54 PM
From: semi_infinite	Read Replies (2) \| Respond to of 3027

The slides below from the FDA generics division indicates that a "minor deficiency" descriptor would happen in a "Not Approvable Letter" with 60 days response. The mode of potential failure in the application process would be labeling and/or bio-inequivalence. Am I reading these slides correctly? fda.gov Last Friday, I sold FEB 13 puts. Yesterday, I sold FED 19 and 20 CCs and 14 puts. I expected a blood bath this morning on the puts. Interestingly, 13 puts premiums shrunk, 14 puts premiums up about 20 cents from my sales price. Something tells me this is the inverse of the Goldman Sachs flash in the pan.